Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging.

BACKGROUND Knowledge of the natural evolution of ischemic brain lesions may be a crucial aspect in the assessment of future stroke therapies. OBJECTIVE To establish daily changes of ischemic cerebral lesion volume using diffusion-weighted magnetic resonance imaging. DESIGN Prospective cohort study. SETTING Referral center. PATIENTS AND METHODS Serial magnetic resonance imaging scans were performed in consecutive untreated stroke patients. The baseline scan was obtained within 48 hours after symptom onset; subsequent scans, 12 to 48 hours, 3 to 4 days, 5 to 7 days, and 30 days after baseline. Lesion volumes were measured on each scan by 2 independent observers. MAIN OUTCOME MEASURE Daily change in lesion volume. RESULTS A total of 112 magnetic resonance imaging scans were obtained in 24 patients. An early increase in lesion volume was seen in all patients. Maximum lesion volume was reached at a mean of 74 hours. Lesion volumes increased by a mean (+/- SEM) of 21% +/- 12% during day 2 and 10% +/- 12% during day 3. No significant change occurred during day 4. During days 5, 6, and 7, statistically significant mean (+/- SEM) decreases of 6% +/- 8%, 3% +/- 4%, and 4% +/- 5%, respectively, were observed. CONCLUSIONS Ischemic lesions follow a relatively consistent pattern of growth during the first 3 days and subsequent decrease in size. These data in conjunction with data regarding the evolution of lesion volume during the first 24 hours after symptom onset may be useful in the design of pilot studies of therapies for acute stroke.

[1]  W. Mali,et al.  Diffusion-weighted magnetic resonance imaging in acute stroke. , 1998, Stroke.

[2]  G. Albers,et al.  Diffusion-weighted MRI for evaluation of acute stroke , 1998, Neurology.

[3]  V Beaudouin,et al.  Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. , 1996, Stroke.

[4]  J. Grotta Why do all drugs work in animals but none in stroke patients? 2 Neuroprotective therapy , 1995, Journal of internal medicine.

[5]  S M Davis,et al.  Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI , 1998, Neurology.

[6]  H. Lutsep,et al.  Clinical utility of diffusion‐weighted magnetic resonance imaging in the assessment of ischemic stroke , 1997, Annals of neurology.

[7]  S. Atlas,et al.  Diffusion-weighted MRI in acute subcortical infarction. , 1998, Stroke.

[8]  B. Bell,et al.  CBF and time thresholds for the formation of ischemic cerebral edema, and effect of reperfusion in baboons. , 1985, Journal of neurosurgery.

[9]  P D Lyden,et al.  Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group. , 1999, Stroke.

[10]  G. Schlaug,et al.  Enlargement of human cerebral ischemic lesion volumes measured by diffusion‐weighted magnetic resonance imaging , 1997, Annals of neurology.

[11]  K Minematsu,et al.  Diffusion‐weighted magnetic resonance imaging , 1992, Neurology.

[12]  G. D. del Zoppo Clinical trials in acute stroke , 1998, Neurology.

[13]  K. Lees Cerestat and other NMDA antagonists in ischemic stroke , 1997, Neurology.

[14]  E. Lo,et al.  Pharmacologic Reversal of Acute Changes in Diffusion-Weighted Magnetic Resonance Imaging in Focal Cerebral Ischemia , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  Gottfried Schlaug,et al.  Ischemic lesion volumes in acute stroke by diffusion‐weighted magnetic resonance imaging correlate with clinical outcome , 1997, Annals of neurology.

[16]  R. Ordidge,et al.  Magnetic Resonance Imaging Assessment of Evolving Focal Cerebral Ischemia Comparison With Histopathology in Rats , 1994, Stroke.

[17]  T. L. Davis,et al.  Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. , 1996, Radiology.

[18]  M. Moseley,et al.  Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI , 1996, Brain Research.

[19]  M. O’Brien,et al.  Ischemic Cerebral Edema. A Review , 1979, Stroke.

[20]  W. Koroshetz,et al.  Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators. , 1999, Stroke.

[21]  M. E. Moseley,et al.  Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke , 1998, Neurology.

[22]  J. Kucharczyk,et al.  Early detection of regional cerebral ischemia in cats: Comparison of diffusion‐ and T2‐weighted MRI and spectroscopy , 1990, Magnetic resonance in medicine.

[23]  K Wienhard,et al.  Progressive Derangement of Periinfarct Viable Tissue in Ischemic Stroke , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  L H Schwamm,et al.  Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. , 1998, Stroke.